Conferences - Results from #8840

ASCO GU 2018: Best of Journals: Renal Cell Carcinoma - Radiology February 11, 2018

ASCO GU 2018: The Probability of Indolent Versus Aggressive Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment February 11, 2018

ASCO GU 2018: Survival Following Upfront Cytoreductive Nephrectomy Versus Targeted Therapy for Metastatic Renal Cell Carcinoma February 11, 2018

ASCO GU 2018: Management of Metastatic Disease for Adrenocortical Carcinoma and Pheochromocytoma February 11, 2018

ASCO GU 2018: Timing and Patient Selection for Cytoreductive Nephrectomy February 11, 2018

ASCO GU 2018: Value of the Lymph Node Dissection in the M0 and M1 Patient February 11, 2018

ASCO GU 2018: Management of Adrenocortical Carcinoma and Pheochromocytoma Endocrinologic Issues February 11, 2018

ASCO GU 2018: Phase Ib Trial of Cabozantinib in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma or Renal Cell Carcinoma February 11, 2018

ASCO GU 2018: Nivolumab Plus Ipilimumab Versus Standard of Care with Previously Untreated Unresectable or Metastatic Urothelial Carcinoma February 11, 2018

ASCO GU 2018: Safety and Efficacy of Nivolumab in Metastatic Renal Cell Carcinoma: Results From the NIVOREN GETUG-AFU 26 Study February 11, 2018

ASCO GU 2018: Subgroup Analysis of Progression-free Survival and Objective Response Rate in the Alliance AO31203 CABOSUN trial - Advanced Renal Cell Carcinoma February 11, 2018

ASCO GU 2018: RNA-sequencing to Identify Three Different Molecular Grades and Immune Checkpoint Cascades with Distinct Clinical Behavior in NMIBC February 11, 2018

ASCO GU 2018: The Role of Metastatic Burden in Cytoreductive/Consolidative Radical Cystectomy February 11, 2018

ASCO GU 2018: Using Grade of Tumor Recurrence After BCG to Guide Further Therapy February 11, 2018

ASCO GU 2018: Impact of Medicaid Expansion on Diagnosis and Management of Patients with Testicular Cancer February 11, 2018

ASCO GU 2018: Rapid Abstract: Long-term functioning in germ-cell tumor survivors. February 11, 2018

ASCO GU 2018: Best of Journals: Kidney Cancer - Urology February 11, 2018

ASCO GU 2018: Best of Journals: Kidney Cancer - Medical Oncology February 11, 2018

ASCO GU 2018: Optimal Sequencing of First and Second Line Systemic Therapy in Metastatic Clear Cell Renal Cell Carcinoma February 11, 2018

ASCO GU 2018: Status of Adjuvant Therapy in Renal Cell Carcinoma in 2018: Completed Trials and What Is Being Tested? February 11, 2018

Page 443 of 620